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Abstract (150 words) 
 
This study assessed temporal changes in the molecular epidemiology of the bacteremic 
Escherichia coli isolates producing CTX-M-14 in Hong Kong. Blood isolates from 1996-
1998 (period 1, n=50) and 2007-2008 (period 2, n=117) were investigated by molecular 
methods. CTX-M-type ESBL was carried by 98.2% (164/167) of the isolates. In both periods, 
the CTX-M-9 group and CTX-M-14 allele were the predominant ESBL type. The major 
clones were found to change from ST68 and ST405 in period 1 to ST131, ST69 and ST12 in 
period 2. Among 65 CTX-M-14-producing plasmids investigated further, 54 had the FII 
replicon. Replicon sequence typing and plasmid PCR-restriction fragment length 
polymorphism showed that 79.6% (43/54) of the FII plasmid subset were similar to the 
completely sequenced plasmid, pHK01 (human urine, Hong Kong, 2004). These pHK01-like 
plasmids were found to have spread to the major clones (ST68, ST405 and ST131) and 
multiple singleton isolates of all four phylogenetic groups. 
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1. Introduction 
 In Asia, the burdens of cefotaximase (CTX-M) producing Enterobacteriaceae have 
increased dramatically in the last decade (Hawkey, 2008; Ho et al., 2005; Ho et al., 2007). 
Studies from Hong Kong, mainland China, South Korea and Thailand have consistently 
showed that CTX-M-14 is the most prevalent enzyme (Ho et al., 2007; Lo et al., 2010; 
Nguyen et al., 2010; Yi et al., 2010). This CTX-M allele was first described in 2001 among E. 
coli, Klebsiella pneumoniae and Shigella isolates collected from different parts of South 
Korea in 1995 (Pai et al., 2001). While clonal spread have been reported in Japan and Canada 
(Pitout et al., 2005; Suzuki et al., 2009), the spread of CTX-M-14 have been found to be 
mainly caused by conjugative plasmids (Cottell et al., 2011; Ho et al., 2011c; Valverde et al., 
2009). In Spain, the spread of CTX-M-14 from 2000 to 2005 was largely due to pRYC105-
like plasmids of the IncK incompatibility group disseminated among diverse E. coli lineages 
(Valverde et al., 2009). Recently, it has been showed that pRYC105 is similar to the pCT 
plasmid that has been found in bacteria from the United Kingdom, mainland China and 
Australia (Cottell et al., 2011). Recently, we sequenced the IncFII epidemic plasmid, pHK01 
and showed that it has disseminated widely among E. coli isolates collected from patients 
with community-acquired, urinary tract infections in 2004 (Ho et al., 2007; Ho et al., 2011c). 
Variants closely related to pHK01 have been identified among Enterobacteriaceae isolates 
from mainland China and Vietnam (Ho et al., 2011c; Nguyen et al., 2010; Yi et al., 2010). 
In this study, we investigated the clonal structure and relatedness of plasmids 
encoding CTX-M-14 for a collection of blood culture E. coli isolates from patients treated in 
a healthcare region from 1996 to 2008.  
 
2. Methods 
2.1 Bacterial strains and susceptibility testing 
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The E. coli isolates were recovered from blood cultures of patients who were treated in a 
healthcare region in Hong Kong (Ho et al., 2002; Ho et al., 2005). The healthcare region 
(QMH) include a network of 5 public hospitals, including 1 acute care, university teaching 
hospital with 1500 beds and all the clinical disciplines including renal, liver and bone marrow 
transplantation service and 4 convalescence care hospitals with 110 to 524 beds. (Ho et al., 
2005).  This study included isolates recovered from two time periods, 1996-1998 (period 1) 
and 2007-2008 (period 2). The proportion of extended-spectrum β-lactamases (ESBL)-
producing E. coli among all blood culture E. coli isolates for period 1 and period 2 were 6.6% 
(74/1127) and 26.8% (253/945), respectively (Ho et al., 2002; Ho et al., 2011b). For period 1, 
67.6% (50/74) of the ESBL-producing isolates remained viable and all were included. The 
clinical characteristics for the 50 patients have been described (Ho et al., 2002). For period 2, 
46.2% (117/253) of the ESBL-producing isolates from 253 patients (one per patient) were 
randomly selected for inclusion. Only one ESBL-producing isolate per patient was included 
in this study. For those patients with more than one isolate, only the first isolate was tested. 
The VITEK GNI system (bioMerieux, Vitek Inc., Hazelwood, MO, USA) was used for 
bacterial identification. The disc diffusion method was used for susceptibility testing and 
results interpreted according to the CLSI (Clinical and Laboratory Standard Institute, 2011). 
Production of ESBL was determined by the double-disc synergy test (Ho et al., 2000; Ho et 
al., 2007).  
 
2.2 CTX-M gene detection and epidemiological typing 
Genes related to the CTX-M families were sought by PCR and sequencing using primers 
previously described (Lo et al., 2010; Saladin et al., 2002). Selected isolates were studied by 
pulsed-field gel electrophoresis (PFGE) of XbaI-digested genomic DNA (Amersham 
Pharmacia Biotech, Little Chalfont, UK) and patterns were analysed with Gelcompar II 
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software (Applied Maths). A multiplex PCR was used to assign the E. coli isolates to one of 
the four main phylogenetic groups (A, B1, B2 and D) (Ho et al., 2007). Multilocus 
sequencing was performed as described (Wirth et al., 2006). PCR reactions were used for 
detection of the 15 major O serotypes (O1, O2, O4, O6, O7, O11, O12, O15, O16, O18, O25, 
O75, O86, O102, and O157) and the O25b subtype (Clermont et al., 2007; Clermont et al., 
2009; Deschamps et al., 2009).  
 
2.3 Conjugation and replicon typing 
Conjugation experiments and sizing of plasmids were carried out as described previously (Ho 
et al., 2011d; Ho et al., 2011c). The replicon (rep) content in the plasmids was determined by 
PCR and sequencing (Carattoli et al., 2005). When a transconjugant cannot be obtained, the 
replicon type for the plasmid encoding CTX-M-14 was determined in the parent strains. In all 
the isolates, the replicon location in the plasmids was confirmed by hybridization with probes 
specific for blaCTX-M-14 and rep amplified by PCR from different samples (Ho et al., 2011d; 
Ho et al., 2011c). The FII plasmids were categorized by the FAB formula using the replicon 
sequence typing scheme (Villa et al., 2010).  
 
2.4 Analysis of blaCTX-M-14 genetic support 
Based on published studies and sequences deposited in the GenBank database, eight different 
types of blaCTX-M-14 genetic support have been reported. For purpose of description, they were 
denoted types I to VIII. Monoplex PCRs using different primer pair combination was used to 
map the genetic support to one of the recognized type (Table S1).  
 
2.5 PCR-RFLP analysis of FII plasmids 
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The FII plasmids were analysed further by a PCR-RFLP method previously described by us 
(Table S2) (Ho et al., 2011c).  
 
2.6 Statistical analysis 
The Chi square test was used to compare categorical variables between the two time periods. 
A P value of <0.05 was considered to indicate statistical significance. All statistic analysis 
was performed by the Epi Info software (version 3.5.1, Centers for Diseases Control and 
Prevention). A Dice coefficients similarity threshold of 85% was used to resolve unique 
PFGE groups (Ho et al., 2007; Lo et al., 2010). 
 
3. Result 
3.1 Antimicrobial susceptibilities and ESBL types 
The isolates often exhibit co-resistance to the non-β-lactam antibiotics. The overall resistance 
rates for isolates from period 1 (n=50) and period 2 (n=117) were: cotrimoxazole, 84% and 
54.7%; ciprofloxacin, 78% and 59.8%; and gentamicin, 78% and 48.7%. Most isolates were 
susceptible to amikacin (98% and 97.4%), and piperacillin-tazobactam (84% and 97.4%). All 
isolates were susceptible to imipenem at the traditional breakpoint (inhibition zone diameter 
≥16 mm, equivalent to MIC ≤4 mg/L). All isolates in period 2 were susceptible to imipenem 
at the new CLSI breakpoint (inhibition zone diameter ≥23 mm and equivalent to MIC ≤1 
mg/L). However, only 90% of the isolates from period 1 were susceptible and 10% (5/50) 
isolates were imipenem-intermediate (inhibition zone diameters, 20-22 mm, and equivalent to 
MIC 2 mg/L).  
 PCR with CTX-M specific primers showed that CTX-M-type ESBL was carried by 
98.2% (164/167) of the ESBL-producing isolates (Table 1). The CTX-M gene in 109 isolates 
was sequenced and a total of five alleles (CTX-M-14, -9, -27, -15 and -79) were found. In 
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both periods, the CTX-M-9 subgroup and CTX-M-14 allele were the predominant CTX-M-
type ESBL.  
 
3.2 Epidemiological typing of strains 
Table 2 summarised findings from the epidemiological typing. Phylogenetic PCR showed 
that 56.3% (94/167) of the isolates were phylogenetic group D, 34.1% (57/167) were group 
B2, 7.2% (12/167) were group A and 2.4% (4/167) were group B1. The proportion of 
phylogenetic group D had decreased from 84% (42/50) in period 1 to 44.4% (52/117) in 
period 2 (P<0.001, chi-square test). Conversely, phylogenetic B2 isolates had increased from 
6% (3/50) in period 1 to 46.2% (54/117) in period 2 (P <0.001).   
Overall, 41.3% (69/167) of the isolates could be assigned to five clones: ST68, ST405, 
ST131, ST69 and ST12 (Table 2). All five clones were producers of the CTX-M-14 allele. 
The remaining 98 isolates were either singleton (n=85) or PFGE nontypeable (n=13). Strains 
belonging to the ST68 and ST405 clones had decreased from 30% (15/50) and 26% (13/50) 
in period 1, to 2.6% (3/117) and 0% (0/117) in period 2, respectively (P<0.01). On the 
contrary, strains related to the ST131 clone increased from 0% in period 1 to 25.6% (30/117). 
The other two clones (ST69 and ST12) were only found in period 2.  
 
3.3 Replicon types of CTX-M-14 encoding plasmids 
A subset of 65 CTX-M-14 isolates, including 15 isolates from period 1 and 50 isolates from 
period 2 was investigated further. The subset was chosen according to the clones (Table 2). 
One to seven isolates for each clone and about half of the singleton isolates in each period 
were chosen. At least one isolate for each unique PFGE within the same MLST was chosen. 
In conjugation experiments, the plasmids harbouring CTX-M 14 could be transferred in 
84.6% (55/65) of the isolates at high frequencies (mean, 10-2 per donor cells). In all 
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transconjugants, the ESBL phenotype was the only resistance detected and there was no co-
transfer of resistance to ciprofloxacin, chloramphenicol, cotrimoxazole, gentamicin, nalidixic 
acid and tetracycline. 
Six different replicons (FII, FIA, FIB, I1-I, B/O, K), either alone or in combinations 
were found among the plasmids encoding CTX-M-14 (Table 3). Replicon FII was equally 
prevalent among CTX-M-14 plasmids in both periods (80%, 12/15 versus 72%, 36/50; 
P=0.7). 
 
3.4 Genetic environment of the blaCTX-M-14 gene 
PCR mapping and sequencing of representative products categorised the genetic environment 
of the 65 CTX-M-14 genes into four different types (gene arrays): type II (ISEcp1-blaCTX-M-
14-IS903, n=59), type III (ΔISEcp1-IS10-blaCTX-M-14 -IS903, n=4), type IV (IS26-ΔISEcp1-
blaCTX-M-14-IS903, n=1) and type VII (Class 1 integron- orf1 - ISEcp1- blaCTX-M-14 - IS903, 
n=1). The class 1 integron in the isolate with type VII context was found to contain genes 
encoding integrase (Δintl1), aminoglycoside resistance (aacA4), chloramphenicol resistance 
(cmlA), quaternary ammonium compound resistance (qacEΔ1), and sulphonamide resistance 
(sul1), as in the multi-replicon FII/FIB plasmid pETN48 (GenBank accession FQ482074, 
originating from a E. coli strain TN48 from an adult with urinary tract infection in 2004 in 
Paris). The proportions of CTX-M-14 genes from period 1 and period 2 with type II 
environment were 80% (12/15) and 94% (47/50), respectively. Those for type III 
environment were 20% (3/15) and 2% (1/50), respectively (P=0.1). The two isolates with 
type IV and VII environments were found in period 2.  
 
3.5 Analysis of the FII plasmids 
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All the 54 plasmids with FII replicon ( additional F1A/F1B replicons) were investigated 
further by replicon sequence typing and PCR-RFLP analysis (Table 4). Replicon sequence 
typing revealed that there were eight FII (F2, F11, F18, F29, F31, F35, F47 and F49), two 
FIA (A1 and A4) and four FIB (B1, B6, B10 and B26) alleles with 11 unique FAB formulas. 
According to the PCR-RFLP patterns for the seven loci, 29 unique profiles were obtained for 
the 54 plasmids. These included 20 plasmids (group 1) with all seven PCR-RFLP patterns 
identical to the reference plasmid (pHK01), 23 plasmids (group 2) with identical restriction 
patterns at three to six loci, and 11 plasmids (group 3) with identical restriction patterns in 
less than three loci. Hence, 79.6% (43/54) of the plasmid subset had pRFLP profiles that were 
identical to that for pHK01 at three or more loci. The presence of the yac (plasmid stability 
system), malB (maltoporin), eitA/eitC (iron transport system) and parAB (plasmid partition) 
genes were assessed by monoplex PCRs using the purified plasmids as template. The result 
showed that all group 1 plasmids and most (91.3%, 21/23) group 2 plasmids were positive for 
all targets. In contrast, these genes were variably found among group 3 plasmids. Group 1 
and 2 plasmids were found in isolates from both time periods and harboured by the major 
clones (ST68, ST405 and ST131) and multiple singleton isolates.  
 
4. Discussion 
This study demonstrated the dissemination of pHK01-like plasmids encoding CTX-M-14 
among hospital E. coli isolates of diverse genetic lineages and their persistence in our locality 
from more than a decade ago. These pHK01-like plasmids were widespread among the 
collection of community CTX-M-14-producing E. coli strains reported by us earlier (Ho et al., 
2007; Ho et al., 2011c). The finding confirms the suspicion that the same epidemic plasmid 
was involved in the dissemination of CTX-M-14 among bacteria in different ecological 
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niches. It also established that CTX-M-14 has been endemic in this region since the mid-
1990s.  
 Our data further showed that dissemination of the pHK01-like plasmids was linked to 
several major E. coli clones (ST405, ST69, ST131) that have previously been associated with 
CTX-M dissemination (Naseer and Sundsfjord, 2011). Of these, ST131 is the most important 
lineage (Rogers et al., 2011). The pandemic spread of ST131 was identified in 2008 during 
the investigation of CTX-M-15 producing E. coli from three continents (Nicolas-Chanoine et 
al., 2008). Subsequently, many ST131 variants including both ESBL-producing and non-
ESBL-producing strains have been described (Lau et al., 2008; Nicolas-Chanoine et al., 2008; 
Rogers et al., 2011). In the pHK01-like plasmids, blaCT-M-14 was the only resistance 
determinant found. Since our ST131 isolates exhibited multidrug resistance involving 
fluoroquinolone, gentamicin and cotrimoxazole, the finding suggested that these ESBL-
producing strains have likely emerged from pre-existing multidrug-resistant strains through 
the capture of CTX-M-14 harbouring, pHK01-like plasmids. Prior to the CTX-M pandemic, 
existing data suggest that ST131 is already one of the major E. coli lineages in human 
infections and are often resistant to fluoroquinolone and multiple other antibiotics (Rogers et 
al., 2011). Our finding that CTX-M-14-producing isolates of ST131 encompassed multiple 
PFGE groups suggests that diversification has occurred within this lineage. Although in most 
parts of the world, especially for Europe the ST131 lineage is often associated with CTX-M-
15 (Lau et al., 2008; Naseer and Sundsfjord, 2011), our result and other reports showed that 
the dominant CTX-M allele among ST131 strains in Asia is CTX-M-14 (Shin et al., 2011; 
Suzuki et al., 2009). Of note, ST131 and ST69 that seems to be emerging in period 2 
represent lineages that were usually associated with high virulence gene content (Blanco et al., 
2011). This could partially explain reports of CTX-M-14-producing isolates among young 
and healthy individuals with community-acquired infections (Ho et al., 2007) and the marked 
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increase in ESBL incidence among E. coli isolates in the last few years (Ho et al., 2011a). In 
our healthcare region, the incidence rate of ESBL-producing E. coli bacteremia (as episodes 
per 10,000 admissions) had increased from 1.9 in 1996-1998 (period 1) to 6.0 in 2003 and 8.5 
in 2007-2008 (period 2) (Ho et al., 2002; Ho et al., 2011b).    
 Multiple PFGE patterns were also found among ST68 and ST405 isolates, indicating 
that these two clones had also diversified. Interestingly, ST405 which was found in period 1 
was not found in period 2. In recent studies, ST405 along with ST131 were important clones 
associated with the dissemination of CTX-M genes (Naseer and Sundsfjord, 2011; Shin et al., 
2011). Besides a change in the major clones, there was an increase in proportion of singletons, 
a decrease in phylogenetic group D and an increase in phylogenetic group B2 isolates in 
period 2. In general, phylogenetic group B2 isolates are known to possess more virulence 
factors (Ferjani et al., 2011). It is possible that the higher virulence of phylogenetic group B2 
isolates might give them an advantage for their increased prevalence in period 2. The 
increased in singletons in period 2 indicated that the pHK01-like plasmids have disseminated 
more widely in different bacterial populations. Given the expansion small number of 
successful clones and the horizontal transfer of pHK01-like incompatibility FII plasmids, a 
change in antibiotic strategies for empirical therapy of presumed E. coli infection is necessary. 
Since pHK01-like plasmids are especially prevalent among isolates causing urinary tract 
infections, empirical therapy for critically ill patients with presumed E. coli bacteremia or 
serious urosepsis should include a carbapenem while waiting for the culture and sensitivity 
results (Meier et al., 2011).   
 In both the FII and non-FII plasmids, the predominant genetic context for blaCTX-M-14 
consisted of an upstream ISEcp1 and a downstream IS903. These mobile elements might be 
involved in mobilization of blaCTX-M-14 across different plasmid platforms. In the PCR-RFLP 
scheme, two loci (B1 and B2) were designed to assess genetic organization of the variable 
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region bearing blaCTX-M-14, including the regions outside the two IS elements. In almost all the 
isolates, the restriction patterns correlated with a conserved array of genes in the variable 
region (yac-malB-IS903-blaCTX-M-14-ISEcp1-eitABCD) inserted between the blocks of 
replication genes and the partition genes. GenBank search revealed that this array of genes is 
specific to pHK01-like plasmids. 
 This study characterised the IncFII plasmids by replicon sequence typing and a PCR-
RFLP plasmid typing scheme. Although the replicon sequence typing method is easy to use, 
our finding showed that it cannot accurately reflect similarity or variations in the plasmid 
scaffold. Plasmids with identical or highly similar pRFLP profiles could exhibit different 
FAB formulas. On the other hand, plasmids with entirely different pRFLP profiles could have 
the same FAB formula. The diversity in FAB formula and various plasmid backbone blocks 
support the notion that this group of pHK01-like plasmids is evolving, and presumably 
reflecting DNA rearrangements, mutations, gene loss and integration of mobile elements.  
 In conclusion, this study showed that the spread of CTX-M-14 among bacteremic E. 
coli isolates in this region is associated with the expansion of small number of successful 
clones and the horizontal transfer of pHK01-like incompatibility group FII plasmids.  
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Table 1. Distribution of CTX-M subgroups and alleles among the ESBL-producing E. 
coli isolates 
 No. (%) 
 Period 1 Period 2 Total 
CTX-M subgroupa     
   M9 49 (98.0) 101 (86.3) 150 (89.8) 
   M1 - 12 (10.3) 12 (7.2) 
   M1+ M9 - 2 (1.7) 2 (1.2) 
   negative 1 (2.0) 2 (1.7) 3 (1.8) 
   subtotal 50 (100) 117 (100) 167 (100) 
CTX-M alleleb    
   CTX-M-14 47 56 103 
   CTX-M-9 2 1 3 
   CTX-M-27 - 1 1 
   CTX-M-15 - 1 1 
   CTX-M-79 - 1 1 
   subtotal 49 60 109 
a PCR with CTX-M subgroup-specific primers. 
b CTX-M-14, -9 and -27 are members of the CTX-M-9 subgroup while CTX-M-15 and -79 
are members of the CTX-M-1 subgroup. All CTX-M-14 sequences were identical to the 
CTX-M-14a variant (AF252622). 
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Table 2. Characteristic of 167 bacteremia ESBL-producing E. coli according to time 1 
period. 2 
Clonea n No. of 
PFGE 
groupsc
No of isolates, by 
phylogenetic group 
No. of isolates 
(No. of isolates 
chosen for plasmid 
analysis) 
   A B1 B2 D Period  
1 
Period 
2 
NT-ST68/CTX-M-14 18 3 - - - 18 15 (2) 3 (1) 
O102-ST405/CTX-M-14 13 2 - - - 13 13 (2) - 
O25b-ST131/CTX-M-14 30 3 - - 30 - - 30 (7) 
O15-ST69/CTX-M-14 5 1 - - - 5 - 5 (1) 
O12-ST12/CTX-M-14 3 1 - - 3 - - 3 (1) 
Singletonsb 98 - 12 4 24 58 22 (11) 76 (40) 
         
Subtotal 167 - 12 4 57 94 50 (15) 117 (50)
aThe serotype-sequence type and CTX-M allele were shown. NT, non-typeable. 3 
bIncluding 13 isolates that could not be typed because of auto-digestion. These isolates produce 4 
various CTX-M alleles (-9, -14, -15, and -27) and one isolate was negative for CTX-M. 5 
cDefined at 85% similarity level. 6 
 7 
 8 
 9 
 10 
 15 
 
Table 3. Replicon type of plasmids encoding CTX-M-14, Hong Kong 11 
Replicon typea n Plasmid sizes, kb No. (%) 
  Period 1 Period 2 
FII 48 70-150 12 (80.0) 36 (72.0) 
FII, FIA, FIB 3 90-100 - 3 (6.0) 
FII, FIB 2 70-150 - 2 (4.0) 
FII, FIA 1 50 - 1 (2.0) 
FIA, FIB 1 50 1 (6.7) - 
I1-I 3 100 2 (13.3) 1 (2.0) 
B/O 2 100 - 2 (4.0) 
K 1 100 - 1 (2.0) 
non-typable 4 70-100 - 4 (8.0) 
Total 65  15 (100) 50 (100) 
 12 
 13 
14 
 16 
 
Table 4. Characteristics of IncFII plasmids encoding CTX-M-14   15 
  No of plasmidsc  
 Group 1 Group 2 Group 3 
Number of plasmids 20 23 11 
FAB formula    
F2:A-:B- 19 5 1 
F35:A-:B- - 16 3 
Othersa 1 2 7 
PCR profile    
malB-yac-eitA-eitC-parAB 20 21 1 
Othersb - 2 3 
None - - 7 
Time    
Period 1 9 2 1 
Period 2 11 21 10 
Clonal group    
ST68 2 1 - 
ST405 1 1 - 
ST131 3 2 2 
ST69 - - 1 
Singletons 14 19 8 
aIncluding group 1: F47:A-:B- (n=1), group 2: F11:A-:B- (n=1) and F49:A-:B- (n=1), group 3: 16 
F18:A-:B- (n=1), F2:A1:B-(n=1), F29:A-:B10 (n=1), F31:A-:B6 (n=1), F31:A4:B1 (n=2), 17 
F31:A4:B26 (n=1). 18 
bIncluding the following profiles: malB-yac-eitA-parAB (n=1), malB-yac-eitC-parAB (n=1), 19 
eitA-eitC-parAB (n=1), eitA-eitC (n=1) and eitA (n=1). 20 
cThe plasmids were categorised according to their similarity to the reference plasmid: group 1, 21 
all seven PCR-RFLP patterns were identical to reference; group 2, three to six restriction 22 
patterns were identical; and group 3, less than three restriction patterns were identical.  23 
 24 
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